nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances and challenges in neurostimulation for headaches
|
Magis, Delphine |
|
2012 |
11 |
8 |
p. 708-719 12 p. |
artikel |
2 |
Being comatose: why definition matters
|
Wijdicks, Eelco FM |
|
2012 |
11 |
8 |
p. 657-658 2 p. |
artikel |
3 |
Brains: the mind as matter
|
Yaqub, Farhat |
|
2012 |
11 |
8 |
p. 667- 1 p. |
artikel |
4 |
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
|
Clark, Christopher M |
|
2012 |
11 |
8 |
p. 669-678 10 p. |
artikel |
5 |
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
|
Svenningsson, Per |
|
2012 |
11 |
8 |
p. 697-707 11 p. |
artikel |
6 |
Corrections
|
|
|
2012 |
11 |
8 |
p. 658- 1 p. |
artikel |
7 |
Corrections
|
|
|
2012 |
11 |
8 |
p. 658- 1 p. |
artikel |
8 |
Corrections
|
|
|
2012 |
11 |
8 |
p. 658- 1 p. |
artikel |
9 |
Dag Aarsland: moving Parkinson's disease forward
|
Holmes, David |
|
2012 |
11 |
8 |
p. 665- 1 p. |
artikel |
10 |
Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions
|
Jox, Ralf J |
|
2012 |
11 |
8 |
p. 732-738 7 p. |
artikel |
11 |
Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study
|
Ekman, Urban |
|
2012 |
11 |
8 |
p. 679-687 9 p. |
artikel |
12 |
Imaging cerebral amyloid plaques: clinical perspective
|
Herholz, Karl |
|
2012 |
11 |
8 |
p. 652-653 2 p. |
artikel |
13 |
Imaging neural correlates of mild cognitive impairment in Parkinson's disease
|
Monchi, Oury |
|
2012 |
11 |
8 |
p. 653-655 3 p. |
artikel |
14 |
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets
|
Keep, Richard F |
|
2012 |
11 |
8 |
p. 720-731 12 p. |
artikel |
15 |
Is neurology ready to see the light?
|
Holmes, David |
|
2012 |
11 |
8 |
p. 663-664 2 p. |
artikel |
16 |
Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA?
|
Stöllberger, Claudia |
|
2012 |
11 |
8 |
p. 659- 1 p. |
artikel |
17 |
Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA? – Author's reply
|
Hankey, Graeme J |
|
2012 |
11 |
8 |
p. 660-661 2 p. |
artikel |
18 |
May, 2012
|
|
|
2012 |
11 |
8 |
p. 666- 1 p. |
artikel |
19 |
Measuring the epilepsy treatment gap in sub-Saharan Africa
|
Winkler, Andrea S |
|
2012 |
11 |
8 |
p. 655-657 3 p. |
artikel |
20 |
News in brief
|
|
|
2012 |
11 |
8 |
p. 668- 1 p. |
artikel |
21 |
Primary or secondary prevention for AD: who cares?
|
Frisoni, Giovanni B |
|
2012 |
11 |
8 |
p. 661-662 2 p. |
artikel |
22 |
Ralf J Jox
|
|
|
2012 |
11 |
8 |
p. 666- 1 p. |
artikel |
23 |
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study
|
Mbuba, Caroline K |
|
2012 |
11 |
8 |
p. 688-696 9 p. |
artikel |
24 |
The changing landscape of traumatic brain injury research
|
The Lancet Neurology, |
|
2012 |
11 |
8 |
p. 651- 1 p. |
artikel |